Faes Farma, S.A. (BME:FAE)
Spain · Delayed Price · Currency is EUR 4.510
+0.025 (0.56%)
At close: Mar 18, 2026
Faes Farma Revenue
In the year 2025, Faes Farma had annual revenue of 626.99M EUR with 22.93% growth. Faes Farma had revenue of 172.99M in the quarter ending December 31, 2025, with 47.70% growth.
Revenue
626.99M
Revenue Growth
+22.93%
P/S Ratio
2.24
Revenue / Employee
331.04K
Employees
1,894
Market Cap
1.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 626.99M | 116.95M | 22.93% |
| Dec 31, 2024 | 510.04M | 36.95M | 7.81% |
| Dec 31, 2023 | 473.09M | 11.38M | 2.46% |
| Dec 31, 2022 | 461.72M | 33.08M | 7.72% |
| Dec 31, 2021 | 428.64M | 17.15M | 4.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.52B |
| Almirall | 1.11B |
| Laboratorios Farmaceuticos Rovi | 743.48M |
| Laboratorio Reig Jofre | 336.68M |
| Clínica Baviera | 304.91M |
| Prim, S.A. | 240.68M |
| Atrys Health | 226.24M |
| Pharma Mar | 221.39M |